The BioEscalator, the University of Oxford’s biomedical incubator, is very proud to be home to a stellar collection of companies using cutting-edge science to tackle profound medical challenges. One of the roles of the BioEscalator, which is part of the Medical Sciences Division, is to help them find the partners and investors needed to develop their businesses.
The new Portfolio 2025 brings the companies together to showcase their innovative approaches for potential partners and investors.
The Portfolio 2025 includes:
- A foreword from Tim Funnell, Partner at Monograph Capital, co-founder of University of Oxford spin-out Miro Bio alongside Professor Simon Davis and Professor Richard Cornall
- One-page profiles of our tenants, from scientific foundation and funding to achievements and ambitions
- A map of their partners and investors across the world
- Our alumni – companies which have graduated from the BioEscalator to continue their development and expansion elsewhere
- BioEscalator achievement metrics
We hope you find this Portfolio 2025 an enjoyable guide to the activities of BioEscalator tenants – you can contact the team if you would like to visit or know more.